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Abstract In this study, in order to investigate the
anticancer mechanism of Calvatia gigantea extract,
edible mushroom species, which belong to Lycoper-
daceae family, changes of CCND1, CCND2, CDK4,
p21, Akt, Bax, Bcl-2, p53, caspase-3 and caspase-9 were
evaluated in A549 lung cancer cells. Cytotoxic effect of
C. gigantea extract was evaluated by using XTT (2,3-
bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetra-
zolium-5 carboxanilide). The C. gigantea extract was
treated in a time and dose dependent manner within the
range 25 lg/ml–2 mg/ml to determine the IC50 dose.
IC50 dose for C. gigantea extract was detected as
500 lg/ml for 72 h. According to expression results,
while CCND1, CCND2, CDK4, Akt and Bcl-2 expres-
sion clearly decreased, Bax, p53, caspase-3 and cas-
pase-9 expression clearly increased in the dose group
cells (A549 cells treated with 500 lg/ml dose of
C. gigantea extract for 72 h). However, there was no
change in p21 expression. C. gigantea extract induced
cell cycle arrest and apoptosis by decreasing the
CCND1, CCND2, CDK4, Akt and Bcl-2 expression
and by increasing Bax, p53, caspase-3 and caspase-9
expression in A549 cells. Mushrooms are eukaryotic
organisms heavily used because of their supposedly
anticancer effect. Many mushroom species have been
used for medical purposes, as a result of also having
many effects such as antibiotic, antiviral and anticancer
effects. It is thought that theC. gigantea extract may be a
significant agent for treatment of lung cancer as a single
agent or in combination with other drugs.
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Introduction
Cancer is caused by genetic changes following the failure
of homeostatic mechanisms. Most chemotherapeutic
agents are used for the treatment of cancer. These agents
can destroy tumors and arrest cancer progress to some
extent, but they may damage healthy cells and tissues.
Thus, new anticancer drugs obtained from natural products
are thought to be less toxic and safer agents to inhibit
cancer (Hann et al. 2002). Increasing cancer-associated
molecular advances lead to less toxic treatments. Dysreg-
ulation in molecular signaling is usually associated with
altered cell growth, cell cycle progression, and corrupted
apoptotic responses in cancer. The dysregulation in
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signaling pathways results from an overexpression and
loss/gain of functional mutations in growth factor receptors
and/or in regulatory proteins (Yamasaki et al. 2007). In
recent years, proto-oncogenes and tumor-suppressor genes
have been used as markers in the diagnosis of cancer.
Apoptosis is the process of programmed cell death and
includes features such as morphological changes, chro-
matin condensation and caspases activation, a family of
cysteine-aspartic acid proteases (Taylor et al. 2008). Cell-
cycle progression in eukaryotes depends on consecutive
activation of cyclin dependent kinase (CDKs), whose
activation is related to cyclin (Pan et al. 2002). CDKs bind
to cyclin at specific intervals during cell cycle progression,
and these complexes are activated (Ahmad et al. 2001).
Cyclin D1 is overexpressed as a result of dysregulated
growth factors or gene amplification in many types of
cancers (Chen et al. 2008).
Lung cancer is the most common cancer type for both
men and women in the world. Lung cancer also has a
high incidence of recurrence and is difficult to treat
(Khuri et al. 2001; Li et al. 2004; Molina et al. 2006).
Non-small cell lung cancer (NSCLC) accounts for
75–80 % of total lung cancer. Despite the fact that lung
cancer treatment methods are constantly improving, this
cancer still ranks as number one cause for cancer related
deaths (Siegel et al. 2014). Most common method of
treatment used for patients with advanced NSCLC is
either cisplatin or platinum-based chemotherapy. How-
ever, these drugs have extremely toxic effects with low
survival profiles (De Petris et al. 2006).
Approximately 2000 mushrooms species are safe for
human consumption as food and approximately 650 of
these mushrooms have medicinal characteristics (Rai
et al. 2005). Medicinal mushrooms constitute a large
group of organisms that are heavily used because of
antiviral, antimicrobial, anti-inflammatory, antihyper-
glycemic, and anticancer effects (Jiao et al. 2013).
Mushrooms are heavily used because of their supposedly
anticancer effect. C. gigantea belonging to the Lycop-
erdaceae family is an edible mushroom species. It was
reported that C. gigantea, which is one of the puffballs,
could be used in cases of ambustion due to its anesthetic
effect. Puffball, belonging to Agaricomycetidae, Agar-
icales, Lycoperdaceae, is a giant-type fungus. It was
shown in several studies that many active compounds
were found in puffball (Kahlos et al. 1989; Nam et al.
2001). Many studies demonstrated that some proteins
and peptides isolated from the puffball have anti-tumor
activity. Anticancer factor calvacin was first isolated
from C. gigantea, which belongs to the basidiomycota
phylum and which has also long been used as a medicinal
food, by Roland et al. (1960).
In a study, it was reported that CULP protein, isolated
from C. caelata, had an anti-proliferative effect on
breast cancer cells (Lam et al. 2001). Moreover, it was
reported that some chemicals or biological agents in
mushrooms inhibit cancer progression by inducing cell
cycle arrest and apoptosis (Hseu et al. 2014).
In this study, we aimed to investigate the anticancer
mechanism of C. gigantea extract by evaluating the
expression chances of CCND1, CCND2, CDK4, p21,
Akt, Bax, Bcl-2, p53, caspase-3 and caspase-9 in A549
human lung cancer cell line. We also demonstrated that
theC.giganteaextract could down regulate the expression
of CCND1, CCND2, CDK4, Akt and Bcl-2, and upreg-
ulate expression of Bax, p53, caspase-3 and caspase-9.
Materials and methods
Macrofungi material and preparation of C.
gigantea extract
Fruit bodies of the C. gigantea samples were collected
in the forest around Gireniz Valley, located in the
western part of Denizli, Turkey during the field works
between 2010 and 2012 years. Identification and
classification of macrofungus were carried out at the
laboratory of the Mushroom Research and Application
Center, Pamukkale University, Denizli, Turkey.
Fresh mushrooms were randomly divided into three
samples of 75 g and then dried in an oven at
40 ± 0.1 C before analysis. Approximately 25 g of
the dried mushroom samples were weighed and then
extracted by stirring with 250 ml of methanol at room
temperature at 150 rpm for 24 h and filtering through
Whatman No. 4 filter paper. The residue was then,
extracted with two additional 250 ml of methanol as
described above. The combined methanolic extracts
were then rotary evaporated at 40 ± 0.1 C to obtain
dry extract, re-dissolved in methanol to a concentra-
tion of 10 mg/ml and stored at 4 C for further use.
Cell culture and chemicals
A549 human lung cancer cell line (obtained from
ATCC, Manassas, VA, USA) was used in this study.
Trizol reagent was purchased from Invitrogen
2076 Cytotechnology (2016) 68:2075–2081
123
(Carlsbad, CA, USA). The following chemicals were
purchased from Biological Industries (Kibbutz, Beit
Haemek, Israel): DMEM medium, penicillin/strepto-
mycin mixture, phosphate buffered saline (PBS), heat-
inactivated fetal bovine serum (FBS), XTT reagent-
cell proliferation kit. Transcriptor first strand cDNA
synthesis kit was purchased from Roche Diagnostics
(Mannheim, Germany). Trypan blue solution, sodium
dodecyl sulfate (SDS), 2-amino-2-(hydroxymethyl)-
1,3-propanediol (TRIS) was purchased from Sigma-
Aldrich Chemical Company (St. Louis, MO, USA).
A549 cells were grown in DMEM medium supple-
mented with 2 mM L-glutamine, penicillin (20 units/
ml), streptomycin (20 lg/ml), and 10 % (vol/vol)
heat-inactivated fetal bovine serum at 37 C in a
saturated humidity atmosphere containing 95 % air
and 5 % CO2. A549 cells were treated with 25, 50,
100,150, 200, 250, 300, 400, 500, 750 lg/ml, 1 and 2
mg/ml C. gigantea extract during 72 h, considering a
time and dose dependent manner.
Cytotoxicity assay
Cytotoxicity assays and determination of IC50 dose ofC.
gigantea extract in A549 human lung cancer cells were
performed by using trypan blue dye exclusion test and
XTT assay as indicated in the manufacturers’ instruc-
tion. Cells were seeded in 96-well tissue plates at a
number of 1 9 104 cells/well and incubated for 24 h
without reagent. After 24 h of incubation, the cells were
treated with various concentrations (0–2 mg/ml) of
extract ofC. gigantea and incubated for 24, 48 and 72 h.
After addition of reagents, cell viability was assessed by
using XTT mixture (0, 1 ml activation solution and 5 ml
XTT reagent) as recommended by the supplier. For-
mazan formation was quantified spectrophotometrically
at 450 nm (reference wavelength 620 nm) using a
microplate reader. The experiment was repeated three
times. Viability was calculated using the background-
corrected absorbance as follows:
Viability %ð Þ ¼ absorbance value of experiment well
=absorbance value of control well
 100
RNA isolation and semi-quantitative RT-PCR
Total RNA was isolated from the cells exposed to IC50
dose (500 lg/ml for 72 h) of C. gigantea extract in
500 ll Trizol Reagent according to the manufacturer’s
instructions. The first-strand cDNA synthesis was
performed by using anchored-oligo (dT) primer and
protector RNase inhibitor according to the manufac-
turer’s protocol (Roche Diagnostics). Appropriate
cycles were chosen to ensure the termination of PCR
amplification.
Semi-quantitative PCR products were analyzed by
2 % agarose gel electrophoresis and visualized by
ethidium bromide staining and photographed under
u.v. light. In this study, CCND1, CCND2, CDK4, p21
and Akt gene expressions were presented with the
comparison of the yield of PCR products with the
housekeeping gene GAPDH. The experiment was
repeated three times.
Western blot analysis
The cells were washed with PBS and then were lysed
under ice-cold condition. Briefly, total protein was
extracted from A549 cells and the dose group using
RIPA buffer (50 mM Tris pH 8, 150 mM NaCl, 1 %
Triton X-100, 0.5 % sodium deoxycholate, 0.1 %
SDS) supplemented with protease inhibitor cocktails.
Protein samples (100 lg protein) were separated on
8.5 % polyacrylamide gels. Proteins were detected
using SuperSignal West Pico Chemiluminescent Sub-
strate (Pierce, Rockford, IL, USA), and bands were
visualized and recorded using GelQuant image anal-
ysis software in a DNR LightBIS Pro image analysis
system (DNR Bio-Imaging Systems Ltd., Jerusalem,
Israel). The experiment was repeated three times.
Statistical analysis
Analyses have been evaluated using the ‘‘Student t
test’’ with the SPSS 17.0 statistical analysis program.
Results
Anti-proliferative effect of C. gigantea extract
in A549 cell line
A549 cell death upon treatment withC. gigantea extract
was assessed using the XTT (2,3-bis-(2-methoxy-4-
nitro-5-sulfophenyl)-2h-tetrazolium-5 carboxanilide)
assay. A cells dose-dependent decrease in the
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susceptibility of A549 cells was found. In this study,
IC50 dose of the C. gigantea extract in the A549 cells
was found to be 500 lg/ml of the 72nd hour (Fig. 1).
Semi-quantitative RT-PCR
In this study, the expression changes of the CCND1,
CCND2, CDK4, p21 and Akt genes were evaluated by
using semi-quantitative PCR method for A549 cells
exposed to C. gigantea extract. mRNA levels were
analyzed in cells treated with C. gigantea extract and
this was compared with the levels of mRNA in
untreated cells. While CCND1, CCND2, CDK4 and
Akt gene expression decreased in the dose group, there
were no expression changes in the p21 gene compared
with control cells (Fig. 2).
Western blot analysis
Based on the results obtained by semi-quantitative
PCR, we analyzed CDK4, Akt, Bax, Bcl-2, p53,
caspase-3 and caspase-9 protein expression in cells
treated with the C. gigantea extract and compared
these results with the levels of proteins in untreated
cells. These protein changes were determined by
Western blot analysis. Western blot analysis results
indicated that CDK4, Akt and Bcl-2 protein expres-
sion decreased and pro-apoptotic protein Bax and cell
cycle checkpoint protein p53 expression increased in
Fig. 1 Concentration and time dependent inhibitory effects of
C. gigantea extract on cell viability in A549 cells. Cell viability
was determined by XTT assay and was reported as the
percentage of viable cells relative to the control. Data are the
average results of three independent experiments and expressed
as mean ± SD
Fig. 2 mRNA expression changes in control and dose groups
(500 lg/ml for 72 h). CCND1, CCND2, CDK4 and Akt gene
expression clearly decreased in the dose group cells. However,
there was no change in p21 expression. (C control group, D dose
group)
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the dose group after 72 h of incubation with C.
gigantea extract (Fig. 3).
Discussion
Several studies reported that different mushroom
extracts have antitumoral activity. Furthermore, sev-
eral studies related to antibacterial and antioxidant
activities of C. gigantea were conducted. Ren et al.
showed that DPPH (1,1-diphenyl-2-picrylhydrazyl)
radical scavenging percentages of C. gigantea extract
was less than 40 % at 10 mg/ml (Ren et al. 2014).
There are studies that are related to the effects of
individual compounds (such as calvacin) of C. gigan-
tea in cancer cells (Roland et al. 1960). However, there
is no information on effects of C. gigantea extract in
cancer cells within our research. The present study is
important in terms of analysing the effect of C.
gigantea extract in A549 cells.
Cancer continues to be one of the highest death
cases among various diseases. Many different types of
anti-cancer drugs have been developed for clinical use
against many different types of cancer, however,
cancer chemotherapy can cause adverse effects, which
can even be a cause of death. For instance, drugs like
sorafenib and sunitinib which are tyrosine kinase
inhibitors are associated with cardio toxicity (Chin-
talgattu et al. 2013). At the same time, the cure rate of
chemotherapy depends on the development of drug
resistance (Meng et al. 2014). Cancer chemothera-
peutic agents may change the regulation of cell cycle
during different processes of the cell cycle, thereby it
causes a decrease in proliferation and induction of
apoptosis in cancer cell. The fact that natural com-
pounds are an alternative approach for the treatment of
cancer has been highlighted in recent studies (Surh
2003). Some studies reported that some of macrofungi
had a strong antibiotic effect and they should be
consumed for health reasons (Jayakumar et al. 2006;
Solak et al. 2006). Furthermore, it was reported that
extracts obtained from these macrofungi slowed down
the development of cancer and tumor cells and some of
them completely stop development of cancer and
tumor cells (Sarangı et al. 2006; Kurashıge et al. 1997;
Wang et al. 1996).
Meng et al. reported that White-line-inducing
principle (WLIP), a lipodepsipeptide isolated from
Lasiosphaera fenzlii Reich that belongs to the same
family as C. gigantea inhibited the growth of K562
human leukemia cells by inducing cell cycle arrest
through PPAR-c (peroxisome proliferator-activated
receptor) (Meng et al. 2014). In another study, it was
indicated that the ubiquitin-like peptide isolated from
C. caelata had a cytotoxic effect on human breast
carcinoma (MDA-MB-231) cells (IC50 = 100 nM)
(Lam et al. 2001). It was pointed out that Calvacia
lilacina (Fam. Lycoperdaceae) affected cell viability
by inducing many apoptosis-related events, such as
mitochondrial transmembrane potential reduction,
mitochondrial cytochrome c release, Bax over-ex-
pression, glutathione depletion, and reactive oxygen
species (ROS) production in several human colon
cancer cell lines, such as SW480, Colo250,
Colo320DM, and DLD-1 cells. It was indicated that
the concentration of 75–150 lg/ml of Calvatia
lilacina could induce marked apoptosis in SW480
cells (Tsay et al. 2009). It is known that calvacin
obtained from C. gigantea has anticancer effect.
Calvacin is a compound purified from an aqueous
extract from the fruit bodies of C. gigantea. It was
reported that this substance had antitumor effects on
experimental animals (Roland et al. 1960). However,
Fig. 3 Effect of C. gigantea extract (500 lg/ml for 72 h) on the
expression of CDK4, Akt, Bax, Bcl-2, p53, Caspase-3 and
Caspase-9 proteins in A549 cells. Western blot was performed
to detect the protein expressions (C control group, D dose group)
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the anticancer mechanism of the C. gigantea extract is
still unclear. We found that C. gigantea extract might
affect the expression of genes of the anti- and pro-
apoptotic super family.
Activation of CDKs and cyclins plays an important
role in cell cycle progression by leading to complex
formation (Bloom and Cross 2007). Cyclin D is a
member of the cyclin protein family which plays a key
role in regulating cell cycle progression. The synthesis
of cyclin D starts at G1 stage and regulates the G1/S
phase transition. Cylin—CDK complexes have a
sequential role in cell cycle and most of these active
oncogenes are inhibited by tumor suppressors. p21 is a
potent cyclin-dependent kinase inhibitor, and thus
functions as a regulator of cell cycle progression
at G1 and S phase (Chen et al. 2015).
Activation of apoptosis occurs via a separate
mitochondrial and/or death receptor signalling cas-
cade (Hellwig et al. 2011). Mitochondrial dysfunction
due to potential releasing of cytochrome c into the
cytosol from the mitochondria is important in apop-
tosis (Fulda and Debatin 2006). The release of
cytochrome c is associated with Bax and Bcl-2, and
it causes the activation of caspase-9 and caspase-3,
which are closely related to apoptosis (Miyazawa et al.
2008). Procaspase-9 is activated by cytosolic cyto-
chrome c, and this leads to the activation of caspase-3,
and finally apoptosis occurs (Jiang and Wang 2004). In
the present study, we found that C. gigantea could
induce caspase-3 and caspase-9 activation in A549
cells. It is thought that the Bcl-2 gene family contains a
number of anti-apoptotic proteins that play an impor-
tant role in resistance against traditional cancer
treatments. Pro-apoptotic proteins such as Bax, Bak
and Bad are members of the same gene family and
have critical importance as they cause apoptosis
(Huang et al. 2012).
In the present study, cytotoxic effects of C.
gigantea extract in A549 cells were detected in a time
and dose dependent manner by using XTT and the IC50
dose of C. gigantea extract in A549 cells was found to
be 500 lg/ml for the 72nd hour. In this study, we
demonstrated that the treatment with C. gigantea can
decrease CCND1, CCND2, CDK4, Akt and Bcl-2
expression levels and can increase Bax, p53, caspase-3
and caspase-9 expression level, suggesting that the C.
gigantea extract can induce cell cycle arrest and
apoptosis in A549 cell.
In conclusion, C. gigantea may inhibit the prolifer-
ation of human lung cancer cells by downregulating the
CCND1, CCND2, Akt and CDK4 genes that play a
significant role in cell cycle arrest in G1/S phase. At the
same time, C. gigantea extract induces apoptosis by
increasing Bax, p53, caspase-3 and caspase-9 that have a
role in apoptosis, and decreasing antiapoptotic protein
Bcl-2 expression. Finally, C. gigantea extract may be a
significant agent for treatment of lung cancer as a single
agent. Thus more studies should be designed to find a
safe dose with the best effects of the C. gigantea.
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